Document de presse | 2025.02.28
On February 27, 2025, Yasmine Belkaid, President of the Institut Pasteur, and Nicolas Dufourcq, CEO of Bpifrance, signed a cooperation agreement aimed at using their resources and skills to improve the transfer to industry of research results. This strategic partnership is designed to encourage the emergence of startups and innovative projects based on the Institut Pasteur’s research. It follows...
News | 2023.05.23
The project "Infectious Diseases Cluster" (IDCluster) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut Pasteur among others.
Article | 2019.05.21
Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to develop innovative drugs (antibiotics, antiparasitic, antifungals, antivirals, antivectors) and therapeutic strategies for safer and sustainable treatments of infectious...
News | 2025.06.30
As part of the video series "My PhD at the Institut Pasteur," which highlights the work of the institute’s PhD students through short and accessible formats, a new episode features Yaëlle Wormser, a doctoral student in microbiology. Through a powerful rap, she raises public awareness about her research on tuberculosis, an infectious disease responsible for over 10 million cases and 1.25 million...
Fiche maladie | 2015.10.06
Aspergillosis is a general term for infections caused by a type of mold (fungus) belonging to the genus Aspergillus. The mold that causes aspergillosis can be found everywhere in the environment in the form of spores, but in certain conditions it can become pathogenic, for example in immunocompromised people or those with chronic lung disease. The diseases caused by Aspergillus differ depending...
Fiche maladie | 2015.10.06
Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by the parasite Trypanosoma cruzi. It primarily occurs in Latin America, where it represents a major public health problem, but cases have also been identified in other regions. Chagas disease is mainly transmitted by triatomine bugs, although it can also be contracted through blood/blood products and mother-to-...
Fiche maladie | 2015.10.06
West Nile virus mainly affects birds, but it can also infect humans and other mammals. It was named after the West Nile district in Uganda, where it was first isolated in 1937 in a woman suffering from high fever. The virus is transmitted through the bite of infected mosquitoes. It primarily occurs in temperate and tropical regions and is endemic in Central Europe, Mediterranean countries and...
Article | 2025.01.20
The complexity of the immune system is a never-ending source of fascination for scientists. The Department of Immunology is composed of teams that investigate the body's natural system of protection against disease.
Document de presse | 2014.11.11
Paris, France - November 13, 2014 - Sanofi and the Institut Pasteur awarded the Sanofi - Institut Pasteur awards for the third consecutive year. Four internationally renowned researchers were honored today for their work carried out in two major fields concerning world health: neglected tropical diseases and immunology.Press releaseNovember 13th, 2014 Created in 2012, these awards encourage...
Document de presse | 2005.04.24
Dengue, a virosis which is raging in tropical areas, is transmitted by mosquitoes. It affects 100 million people each year throughout the world. The genetic analysis of a large cohort of subjects who were hospitalised with this disease in Thailand has enabled researchers at the Institut Pasteur, together with researchers from Inserm (the National Institute for Health and Medical Research), to...